𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Letter to the editor: High-dose methylprednisolone in resistant and relapsed children with acute lymphoblastic leukemia

✍ Scribed by Hiçsönmez, GÖNÜL ;Özsoylu, Şinasi ;Onat, Neşe ;Prozorova, Zamani Vahide ;Gümrük, Fatma ;Tuncer, Murat

Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
141 KB
Volume
22
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Letter to the Editor:FLAG (fludarabine,
Letter to the Editor:FLAG (fludarabine, high-dose cytarabine and G-CSF) for refractory and high-risk relapsed acute leukemia in children
✍ Sarper, Nazan; Yalman, Nevin 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 2 views

## FLAG (Fludarabine, High-Dose Cytarabine and G-CSF) for Refractory and High-Risk Relapsed Acute Leukemia in Children We have read with interest the report about FLAG therapy in childhood acute leukemia by McCarthy et al. [1]. We want to add our experience with IDA-FLAG in poor-risk childhood leuk

The use of higher dose clofarabine in ad
The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia
✍ Bradley A. McGregor; Alexander W. Brown; Michael B. Osswald; Michael R. Savona 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 2 views

## Abstract The standard dose of clofarabine is 52 mg/m^2^ for pediatrics and 40 mg/m^2^ in adults. Clofarabine dosed at 52 mg/m^2^ was used in adult patients with refractory ALL to maximize response before allo‐HSCT. All patients had a significant response to therapy. Published pharmacokinetic ana

High-dose chemotherapy and blood stem ce
High-dose chemotherapy and blood stem cell autografts for children with first relapsed acute lymphoblastic leukemia: A pilot study of the children's cancer and leukemia study group of Japan (CCLSG)
✍ Takaue, Yoichi ;Watanabe, Arata ;Murakami, Tatsuo ;Watanabe, Tsutomu ;Kawano, Yo 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 508 KB

## Abstract This study was performed to determine the value of high‐dose chemotherapy and peripheral blood stem cell autografts (PBSCT) in the treatment of children with first relapsed acute lymphoblastic leukemia (ALL). Eighteen children underwent PBSCT during the second complete remission (CR) an